New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 12, 2013
09:05 EDTSTEMStemCells announce first transplant in phase 1,2 trial in AMD
StemCells announced dosing of the first high-dose patient in the company's Phase 1,2 clinical trial in dry age-related macular degeneration.The patient, the fifth overall in the 16-patient trial, was transplanted yesterday with 1M HuCNS-SC cells. The first four patients each received a dose of 200K cells. An independent Data Safety Monitoring Committee conducted a review of the trial data to date, and found no safety issues to preclude the trial from proceeding to the high dose.
News For STEM From The Last 14 Days
Check below for free stories on STEM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 7, 2014
15:01 EDTSTEMStemCells management to meet with Maxim
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use